Researchers identify a treatment for a rare bone loss disorder that might also lead to help for aging brittle bones
A possible ‘first-line’ treatment for a rare bone loss disease has been identified by a research team led by Tohoku University in Japan. The research findings, published in the journal Molecular Cell, could also provide insight into treating age-related osteoporosis.
Hajdu-Cheney syndrome is a rare genetic disease that leads to severe osteoporosis and developmental defects, including the reabsorption of bones in the hands and feet. The disease is associated with mutations in a particular gene, called NOTCH2, which codes for proteins involved with bone maintenance. The NOTCH2 proteins usually help balance destruction and construction essential for bone maintenance and repair. Mutations associated with Hajdu-Cheney syndrome upset that balance, but the exact mechanisms causing bone resorption have not been well understood.
Now, through a series of detailed tests, molecular biologist Hiroyuki Inuzuka and his colleagues have worked out the specific molecular pathway that results in Hajdu-Cheney syndrome.
They found that this particular NOTCH2 mutation does not maintain normal NOTCH2 protein abundance, with the help of another protein, called FBW7. To discover this, the researchers knocked out the gene for Fbw7 in the bones of mice. Without the gene and resulting protein, the mice had severe osteoporosis, much like people with Hajdu-Cheney syndrome — indicating that FBW7 is the primary regulator of this system.
They further determined that in humans with Hajdu-Cheney syndrome, the FBW7 protein was unable to bind to NOTCH2 proteins because the binding spot is missing in osteoclasts. This mutation allows the osteoclasts to over-operate, breaking down too much bone tissue.
The researchers were able to reverse bone loss in the knock-out mice with the elevated NOTCH2 by giving them a medication that blocks osteoclast formation. They tried several different treatments, including a chemical compound called DAPT that was particularly effective. DAPT has been shown to help with osteoarthritis by inhibiting function of NOTCH proteins in other studies. Using DAPT as well as Zoledronic acid, a common medication for osteoporosis, “may become a first-line treatment for Hadju-Cheney syndrome,” the researchers conclude in their study.
“By clearly identifying the relationship between FBW7 and NOTCH2 proteins, we have identified potential therapeutic targets for patients with rare bone diseases as well as much more widespread age-related osteoporosis,” said Inuzuka.
Learn more: Reversing severe bone loss
The Latest on: Bone loss
via Google News
The Latest on: Bone loss
- Can weighted vests help maintain bone health when older adults slim down?on January 23, 2020 at 12:41 pm
“With the weighted vest, you’re keeping yourself at an equal load while you lose weight,” Beavers said. “We know that not all, but a lot, of bone loss that occurs when you drop pounds is because of ...
- Why cancer treatment causes bone losson January 20, 2020 at 6:04 am
Researchers studying mice have found a driver of bone loss related to cancer treatment. They’ve shown that radiation and chemotherapy can halt cell division in bone, which results in a stress response ...
- Vitamin D Deficiency May Cause Depression And Bone Losson January 20, 2020 at 3:21 am
Calcium and phosphorus are required for better health of your bones. And, these nutrients require vitamin D to be absorbed by the body. Inadequate vitamin D level is one of the significant culprits ...
- Young cancer survivors have lower bone mineral density compared with healthy controls: a nationwide population-based study in Koreaon January 20, 2020 at 2:15 am
Therefore, our aim was to assess the increased risk of bone loss in Korean cancer survivors compared with the healthy general population, and also to evaluate the relationship between body composition ...
- Dr. Zorba Paster: Study links poor social relationships to bone losson January 15, 2020 at 6:00 pm
Wellness is a team sport. A new study published in the British Medical Journal drives this point home. Researchers showed that few or poor social relationships were linked to bone loss in ...
- Investigational Drugs Appear Promising In Treating Bone Loss In Cancer Patientson January 14, 2020 at 7:38 am
A new study pointed out the factors pertaining to bone loss in cancer patients and suggests drugs that can treat it.
- Why cancer treatments cause bone losson January 13, 2020 at 2:01 pm
Red and green lines represent new bone in this image of a normal mouse bone. US researchers say they have found a driver of bone loss related to cancer treatment. Working with mice, they have ...
- Investigational drugs block bone loss in mice receiving chemotherapyon January 13, 2020 at 7:03 am
Bone loss that can lead to osteoporosis and fractures is a major problem for cancer patients who receive chemotherapy and radiation. Since the hormone estrogen plays an important role in maintaining ...
- Investigational Drugs Block Bone Loss in Mice Receiving Chemotherapy (image)on January 13, 2020 at 7:01 am
Exposure to chemotherapy and radiation during cancer treatment leads to bone loss and increases the risk of osteoporosis and fractures. A new study from Washington University School of Medicine in St.
via Bing News